The U.S. Food and Drug Administration (FDA) has given GT Biopharma a green…
Articles by Marisa Horak, MS
Inflammation plays a key role in the progression of polycythemia vera (PV), making it an important potential treatment target.
Artificial intelligence (AI) may help design better CAR T-cell therapies to treat myeloma and other cancers, a study…
The U.S. Food and Drug Administration (FDA) has awarded its breakthrough therapy designation — which aims to speed the development…
Treatment with Tecvayli (teclistamab), an approved cancer drug, can reduce the risk of disease progression in people with high-risk…
The overall risk of any infection in the first year after starting treatment is similar in people given different types…
Bristol Myers Squibb‘s experimental cell therapy arlocabtagene autoleucel (arlo-cel) may help control myeloma…
A CAR T-cell therapy targeting glioblastoma improved tumor control and survival in mice when given before surgery rather than afterward,…
September is Gynecologic Cancer Awareness Month, and advocacy groups are running campaigns to raise awareness about gynecological cancers,…
Since the late 1940s, when the first chemotherapies were introduced, advances in treatment for blood cancers have resulted in…